Creator
Ida Jooste
Guest Author
Want the six-monthly HIV jab? Here’s your nine-step clinic cheat sheet
A step-by-step guide to what really happens at the clinic when you go for lenacapavir, the new six-monthly HIV prevention jab, from initial testing to injection day.
Meet four people who got the HIV prevention jab
As South Africa rolls out the six-monthly HIV prevention injection, Lenacapavir, four people from high-risk groups explain why they chose the shot over daily pills and what their…
SA and Zambia’s HIV shot dilemma: Demand versus supply
South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…
More HIV funding cuts are coming for SA. This time it’s a slow fade, but with clear risks
The Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some…
Superbugs plus climate change equals double trouble. Here’s why
As the Earth becomes hotter, we’re seeing more floods and droughts. Flooding can make superbugs spread faster and further. And heat helps germs adapt faster
Here’s what’s on South Africa’s 2026 public health agenda
We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and what we can’t — this year
The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?
The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex
US making diphtheria great again? Why SA’s public health experts are worried about America’s RFK Jr
Misinformation fuelled by the US health secretary is creating a dangerous – and growing – lack of trust in vaccines
Fighting for funds: A new era of HIV activism
Instead of the Aids denialism of decades past, it’s US funding cuts that could lead to up to 300 000 more HIV infections in the next four years. Activists like Sisonke Msimang…
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support
News for Kids
In a groundbreaking move, the SABC now offers a TV news bulletin specifically designed for children. Ida Jooste looks into the production values behind the concept and gets some…